Patient no. | Age | Gender | Marriage | History (year) | BMI | Fasting glucose | HbA1C (%) | C-peptide (ng/ml)* |
---|---|---|---|---|---|---|---|---|
Group A: Long-standing patients having normal β cell function with oral medications | ||||||||
1 | 60 | M | Yes | 13 | 30.42 | 10.39 | 8.6 | 2.93 |
2 | 38 | M | Yes | 8 | 20.9 | 8.39 | 9.6 | 0.89 |
3 | 53 | M | Yes | 4 | 28.72 | 9.3 | 7.9 | 2.07 |
4 | 41 | F | Yes | 4 | 26.81 | 8.2 | 7.8 | 1.88 |
5 | 29 | M | Yes | 2 | 26.78 | 6.2 | 7.5 | 1.67 |
6 | 43 | F | Yes | 2 | 27.55 | 10.83 | 8.7 | 1.93 |
7 | 61 | M | Yes | 8 | 30.81 | 6.53 | 7.4 | 1.6 |
8 | 68 | F | Yes | 6 | 21.2 | 6.21 | 8.4 | 0.97 |
9 | 40 | M | Yes | 6 | 25.31 | 15.95 | 12.3 | 0.8 |
10 | 36 | M | Yes | 1 | 25.14 | 11.59 | 10.2 | 1.03 |
11 | 54 | F | Yes | 13 | 28.28 | 11.95 | 8.9 | 0.91 |
12 | 55 | F | Yes | 14 | 25.04 | 8.27 | 9.7 | 0.91 |
13 | 57 | M | Yes | 1 | 26.4 | 6.95 | 7.5 | 1.41 |
14 | 54 | M | Yes | 15 | 32.35 | 7.6 | 7.9 | 1.5 |
15 | 45 | F | Yes | 1 | 25 | 9.46 | 8.4 | 1.89 |
16 | 58 | F | Yes | 10 | 22.91 | 8.97 | 9.7 | 1.08 |
17 | 57 | F | Yes | 14 | 23.88 | 7.38 | 7.4 | 1.07 |
18 | 64 | M | Yes | 13 | 32.81 | 8.3 | 8.4 | 2.09 |
Mean | 50 | Â | Â | 7.5 | 26.68 | 9.03 | 8.68 | 1.48 |
(SD) | (11) | Â | Â | (5) | (3.46) | (2.44) | (1.25) | (0.58) |
Group B: Long-standing patients having normal β cell function with insulin injection | ||||||||
19 | 52 | M | Yes | 12 | 28.12 | 10.63 | 9.4 | 1.08 |
20 | 44 | F | Yes | 9 | 24.2 | 10.64 | 8.1 | 0.96 |
21 | 60 | F | Yes | 12 | 23.23 | 11.55 | 10.0 | 1.13 |
22 | 56 | M | Yes | 11 | 28.37 | 12.19 | 7.5 | 1.19 |
23 | 46 | M | Yes | 5 | 29.05 | 7.62 | 7.8 | 1.61 |
24 | 44 | M | Yes | 2 | 31.35 | 10.99 | 8.5 | 1.96 |
25 | 40 | M | Yes | 4 | 24.46 | 9.1 | 7.4 | 1.29 |
26 | 61 | F | Yes | 13 | 30.47 | 11.03 | 8.8 | 1.53 |
27 | 64 | F | Yes | 2 | 27.06 | 8.63 | 8.3 | 1.64 |
28 | 39 | M | Yes | 11 | 28.09 | 10.94 | 9.8 | 1.84 |
29 | 47 | M | Yes | 7 | 26.45 | 7.27 | 7.9 | 1.33 |
Mean | 50 | Â | Â | 8 | 27.35 | 10.05 | 8.5 | 1.41 |
(SD) | (9) | Â | Â | (4) | (2.59) | (1.63) | (0.9) | (0.32) |
Group C: Long-standing patients having impaired β cell function with insulin injection | ||||||||
30 | 66 | F | Yes | 18 | 22.48 | 10.71 | 8.3 | 0.39 |
31 | 39 | M | Yes | 3 | 19.83 | 8.0 | 13.2 | 0.45 |
32 | 55 | F | Yes | 24 | 22.27 | 6.77 | 7.3 | 0.16 |
33 | 54 | M | Yes | 15 | 25.69 | 8.56 | 8.5 | 0.59 |
34 | 49 | F | Yes | 15 | 24.22 | 10.15 | 9.6 | 0.17 |
35 | 54 | M | Yes | 11 | 27.72 | 8.02 | 8.9 | 0.56 |
36 | 47 | M | Yes | 15 | 24.28 | 9.18 | 11.1 | 0.19 |
Mean | 52 | Â | Â | 14 | 23.78 | 8.77 | 9.56 | 0.36 |
(SD) | (8) | Â | Â | (6) | (2.56) | (1.36) | (1.99) | (0.19) |